ICMR-National Institute of Translational Virology and AIDS Research

What ICMR-National Institute of Translational Virology and AIDS Research does

ICMR-National Institute of Translational Virology and AIDS Research (ICMR-NITVAR), headquartered in Pune on a 7-acre campus, is an autonomous government research institute under the Indian Council of Medical Research (ICMR), Ministry of Health & Family Welfare, Government of India. Originally established as the National AIDS Research Institute in October 1992 and renamed to ICMR-NITVAR in 2022, the institute operates as India's designated reference laboratory for HIV/AIDS and translational virology, serving public-sector programmes rather than commercial customers. Its core activities span HIV clinical care (4,000+ patients served through its ART centre free of charge under the National AIDS Control Programme), national HIV Drug Resistance surveillance (including India's first national HIVDR survey), evaluation of 700+ diagnostic kits, and translational research on viral hepatitis, multidrug-resistant tuberculosis, HPV-associated cancers, and other viral infections.

The institute's underlying technical platform comprises a BSL-3 laboratory and advanced instrumentation including the ABBOTT Real Time PCR, BD FACSAria Fusion Cell Sorter, 3730XL DNA Analyzer, confocal microscope, and HPLC. It maintains WHO Collaborating Centre status, is part of the WHO Global Network for HIVDR, holds NABL accreditation, and is approved by CDSCO as a referral laboratory, with active research collaborations with Johns Hopkins, Harvard, Yale, and WHO, plus capacity-building engagements with Myanmar, Indonesia, and Sri Lanka.

The institute is entirely government-funded and does not operate on a commercial revenue model. Funding flows from ICMR grants and NACO programmatic support; ancillary income is limited to nominal training fees of approximately Rs 2,000 per student per month for PhD and short-course programmes. Patient services, kit evaluations, and reference-lab work are delivered on a non-commercial basis in support of national public-health mandates.

Name

ICMR-National Institute of Translational Virology and AIDS Research

Legal name

ICMR - National Institute Of Translational Virology And AIDS Research (NITVAR)

Website

https://nari-icmr.res.in

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

ICMR-NITVAR is a Pune-based Indian government research institute under ICMR, operating as the national reference laboratory for HIV/AIDS and translational virology, delivering free diagnostic, surveillance, and training services under the National AIDS Control Programme.

Ownership category

akta.pro rank

Product category

HIV/AIDS and Translational Virology Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

HIV/AIDS Medicine (HLAKAGAB)

akta.pro secondary industries

General Infectious Disease (HLAKAGAA), Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Pandemic Preparedness & Rapid-Response Vaccines (HLAIAEAF)

Keywords

• HIV/AIDS research
• Clinical virology services
• Diagnostic laboratory services
• Antiretroviral therapy services
• Public health research

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Government Research Funding: Funded by Indian Council of Medical Research (ICMR) and Government of India for conducting public health research, surveillance, and clinical services related to HIV/AIDS and other infectious diseases

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

ICMR-NITVAR is a government research institute conducting multi-disciplinary HIV/AIDS and translational virology research, including virology, immunology, microbiology, molecular biology, epidemiology, clinical research, and socio-behavioral investigations. It provides HIV diagnostic services (viral load testing, drug resistance genotyping, kit evaluation), runs an antiretroviral therapy (ART) centre for over 4000 patients under the National AIDS Control Programme, and offers training programs and external quality assessment through its Proficiency Testing Provider Unit.

Product overview

ICMR-NITVAR is a premier research institute under the Indian Council of Medical Research, devoted exclusively to HIV/AIDS research since its establishment in 1992. The institute operates as a unified research organization offering multiple interconnected services including biomedical research (virology, immunology, microbiology, molecular biology), clinical research through FCCR facilities, diagnostic services (HIV viral load testing, drug resistance genotyping, diagnostic kit evaluation), and healthcare delivery (ART centre with 4000+ patients). The institute also provides educational programs through internships and Ph.D. training, and quality assurance services via its proficiency testing provider unit. All these components work together under the guidance of the National AIDS Control Programme to generate data, build capacity, provide laboratory services, and support surveillance and drug resistance monitoring.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Supports National AIDS Control Programme with surveillance, capacity building, laboratory services, and drug resistance studies
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Johns Hopkins University, USAcoreStrategic or Co-development PartnerInternational research collaboration in HIV/AIDS research and epidemiology
• Harvard University, USAcoreStrategic or Co-development PartnerAcademic research collaboration in public health and virology
• World Health Organization - India OfficecoreStrategic or Co-development PartnerWHO Collaborating Centre designation for HIV diagnosis and monitoring of ART; joint surveillance activities
• Population Council, USAminorStrategic or Co-development PartnerResearch collaboration on population and reproductive health studies
• Yale University, USAminorStrategic or Co-development PartnerAcademic research partnership in health sciences
• National AIDS Control Organization (NACO)coreStrategic or Co-development PartnerPrimary national partner for HIV/AIDS surveillance, capacity building, laboratory services, and drug resistance studies supporting National AIDS Control Programme
• National Institute of Virology, PunecoreTechnology or IntegrationICMR sister institute collaboration for virology research and outbreak investigations
• NIMHANS, BengalurucoreTechnology or IntegrationConsortium partner for diagnostic kit quality evaluation for HIV, HBV, HCV
• National Institute of Cholera and Enteric Diseases (NICED), KolkatacoreTechnology or IntegrationConsortium partner for diagnostic kit quality evaluation for HIV, HBV, HCV
• National Centre for Disease Control (NCDC), DelhicoreTechnology or IntegrationConsortium partner for diagnostic kit quality evaluation for HIV, HBV, HCV
• Pune Municipal CorporationcoreStrategic or Co-development PartnerCollaborative clinical care and research centre for HIV/AIDS services in Pune
• Symbiosis International University, PuneminorStrategic or Co-development PartnerAcademic collaboration for PhD programs and research training

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• National Centre for Disease Control (NCDC): NCDC Delhi is one of NITVAR's four consortium partners for diagnostic kit evaluation and India's apex public health agency for disease surveillance. Both institutions run government-funded infectious disease reference laboratories with overlapping HIV, hepatitis, and outbreak-response mandates.
• ICMR-National Institute of Virology (NIV): Sister ICMR institute also located in Pune and already a named NITVAR collaboration partner. NIV focuses on virology including influenza, Nipah, and COVID-19, overlapping directly with NITVAR's expanded translational virology mandate and competing for the same ICMR grant pool.
• National Institute of Cholera and Enteric Diseases (NICED): NICED Kolkata is the fourth NRL in NITVAR's diagnostic kit evaluation consortium and another ICMR institute conducting infectious disease reference-laboratory work. Comparable in scale, government funding model, and NABL-accredited test portfolio.
• National Institute of Mental Health and Neurosciences (NIMHANS): NIMHANS Bengaluru is a NITVAR consortium partner for diagnostic kit evaluation and a major Indian government biomedical research institution. Both conduct NIH/ICMR-grade clinical and laboratory research with shared NABL-accredited testing infrastructure.

Broad incumbents

• Institut Pasteur: Institut Pasteur is a long-established international research institute with WHO reference laboratory status covering HIV, viral hepatitis, and emerging infections. It shares NITVAR's mix of reference-laboratory work, training programmes, and translational infectious disease research, but with a global footprint and broader funding base.
• Centers for Disease Control and Prevention (CDC): The U.S. CDC operates the global reference laboratory standard for HIV viral load and drug resistance testing. It parallels NITVAR's role as India's reference lab and apex surveillance body, but at much greater scale and with an international mandate.
• U.S. National Institutes of Health (NIH) / NIAID: NIAID is the international benchmark for infectious disease and HIV/AIDS research institutes and operates as a WHO Collaborating Centre on a global scale. Comparable to NITVAR in mandate (HIV, viral immunology, drug resistance) but vastly larger in budget, staff, and global footprint.

Others

• Indian Council of Medical Research (ICMR): ICMR is NITVAR's parent organization and the apex body coordinating India's biomedical research ecosystem. As an umbrella funder of ~30+ institutes, ICMR sets the strategic priorities and grant allocations that determine NITVAR's research direction.
• National AIDS Control Organization (NACO): NACO is NITVAR's primary national partner and funder under the Ministry of Health. Not a research peer per se, but it is the central commissioning body whose priorities and budgets directly shape NITVAR's research agenda and grant flow.

Regional players

• All India Institute of Medical Sciences (AIIMS): AIIMS New Delhi is India's flagship government medical research institution with significant infectious disease and HIV research capacity. While it operates a broader clinical mission, it competes with NITVAR for clinical trial grants, ICMR funding, and senior scientific talent within India.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ICMRNARI
• LinkedInlinkedin.com/company/icmr-national-institute-of-translational-virology-and-aids-research

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICMR-National Institute of Translational Virology and AIDS Research